Bioactivity | BMS-585248 is a potent, third-generation HIV-1 attachment inhibitor with a promising initial in vitro and in vivo pharmacokinetic profile[1]. |
In Vivo | BMS-585248 (静脉注射 (1 mg/kg) 和口服 (5-200 mg/kg); 一次)具有良好的药代动力学特征,雄性大鼠静脉注射 (1mg /kg) 和口服 (5mg /kg) 后,AUC 值分别为 3220 nM·h 和 8064 nM·h。 Animal Model: |
Name | BMS-585248 |
CAS | 619331-12-3 |
Formula | C22H18FN7O3 |
Molar Mass | 447.42 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Regueiro-Ren A, et al. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 13. Synthesis and profiling of a novel amminium prodrug of the HIV-1 attachment inhibitor BMS-585248. J Med Chem. 2013 Feb 28;56(4):1670-6. |